DGS Capital Management, LLC

Position in GSK — GSK plc

CIK 1900110 JERSEY CITY, NJ

Position in GSK

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$2,356,337

+$397,974 QoQ

Shares Held

42,695

+6.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

16 quarters on record

Voting authority Sole 62% Shared 0% None 38%

Healthcare · as of Mar 31, 2026

DGS Capital Management, LLC holds $21,433,187 across 14 Drug Manufacturers - General names. GSK ranks #4 (11.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	13,631	$3,331,961
2	NVS	Novartis AG	21,135	$3,228,371
3	LLY	ELI LILLY & Co	3,475	$3,196,200
4	GSK	GSK plc This page	42,695	$2,356,337
5	GILD	Gilead Sciences, Inc.	14,029	$1,955,221
6	MRK	Merck & Co., Inc.	14,018	$1,686,225
7	ABBV	AbbVie Inc.	6,748	$1,467,622
8	NVO	Novo Nordisk A S	31,948	$1,174,089

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,356,337	42,695	+6.9%	Shares	Sole	2026-04-28
2025-12-31	$1,958,363	39,934	+9.9%	Shares	Sole	2026-02-24
2025-09-30	$1,568,520	36,342	+11.6%	Shares	Sole	2026-02-24
2025-06-30	$1,250,457	32,564	+11.8%	Shares	Sole	2026-02-24
2025-03-31	$1,128,651	29,134	+3.1%	Shares	Sole	2026-02-24
2024-12-31	$956,023	28,268	-17.9%	Shares	Sole	2025-01-21
2024-09-30	$1,407,825	34,438	+3.9%	Shares	Sole	2024-12-10
2024-06-30	$1,275,659	33,134	+8.0%	Shares	Sole	2024-12-10
2024-03-31	$1,315,723	30,691	+1.5%	Shares	Sole	2024-04-15
2023-12-31	$1,120,138	30,225	-19.3%	Shares	Sole	2024-01-30
2023-09-30	$1,358,033	37,463	+13.3%	Shares	Sole	2024-01-30
2023-06-30	$1,178,258	33,060	+18.8%	Shares	Sole	2024-01-30
2023-03-31	$990,547	27,840	+21.3%	Shares	Sole	2023-06-16
2022-12-31	$806,357	22,947	+70.7%	Shares	Sole	2023-02-21
2022-09-30	$395,656	13,444	+116.6%	Shares	Sole	2023-02-21
2022-06-30	$264,960	6,206	—	Shares	Sole	2022-07-28
No filing history on record for this holder in this stock.